1. Pink Sheet

Forest Cuts A New Path But Remains Rooted In Primary Care

 
• By Jessica Merrill

Forest’s new CEO outlined “Project Rejuvenate,” a strategy to recharge the drug marketer, Dec. 2. The program involves headcount and cost reductions and the sale of $1 billion in debt to fund share repurchases and bolt-on acquisitions. But the plan doesn’t call for a change in strategic direction since Saunders intends to strengthen Forest’s commitment to primary care.

Forest Laboratories Inc. will remain firmly grounded in primary care and continue to rely heavily on business development to broaden its portfolio as it moves beyond the Lexapro patent expiration under the leadership of CEO Brent Saunders.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance